ANUBI: A Platform for Affinity Optimization of Proteins and Peptides in Drug Design
Journal of Chemical Theory and Computation · 2026
DOI: 10.1021/acs.jctc.5c01640 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Chemical Theory and Computation, 2026. Verfasst von Damiano Buratto und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Quantitative Biology, College of Life Sciences, Zhejiang University, Hangzhou 310058, China. Hauptthemen laut MEDLINE: Peptides, Proteins, Drug Design, Software. Die Arbeit nennt 54 Literaturangaben. Gefördert von: Zhejiang University, National Key Research and Development Program of China, Xi’an Jiaotong-Liverpool University.
Abstract (Originalsprache)
The increasing availability of computational power opens unprecedented opportunities in computational biology and drug design. Computer simulations based on physical models can now reproduce or replace critical biophysical experiments, such as binding affinity evaluations in the drug screening process. Here, we present ANUBI (ANUBI Nexus for Understanding Binding Interactions), a software package that automates sequence space exploration and binding free energy calculations to optimize protein or peptide drug candidates for improved target binding. Starting from a user-provided molecular model of the drug-target interaction, ANUBI systematically evaluates point mutations in selected regions using Monte Carlo methodology, retaining favorable mutations based on calculated binding affinity differences. We demonstrate that this approach efficiently samples sequence space, generating dozens of optimized variants in timeframes comparable to experimental approaches at substantially reduced cost. As a proof of concept, we applied ANUBI to an antibody-antigen complex and a peptide-protein interaction, identifying variants with significantly improved predicted binding energy (approximately 20 kcal/mol, calculated using the MMPBSA method), within 20 days of computation on a single GPU.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute of Quantitative Biology, College of Life Sciences, Zhejiang University, Hangzhou 310058, China.
- Department of Biosciences and Bioinformatics, School of Science, Xi'an Jiaotong-Liverpool University, Suzhou 215123, China.
- Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool L7 8tX, United Kingdom.
ORCID-Profile: Ruhong Zhou, Francesco Zonta
Förderung
- Zhejiang University
- National Key Research and Development Program of China
- Xi’an Jiaotong-Liverpool University
- Shanghai Artificial Intelligence Lab
- National Center of Technology Innovation for Biopharmaceuticals
Zitieren
APA
Buratto, D., Wang, W., Zhang, X., Zhu, Q., Meng, J., Rigden, D. J., Zhou, R., & Zonta, F. (2026). ANUBI: A Platform for Affinity Optimization of Proteins and Peptides in Drug Design. Journal of Chemical Theory and Computation. https://doi.org/10.1021/acs.jctc.5c01640
Vancouver
Buratto D, Wang W, Zhang X, Zhu Q, Meng J, Rigden DJ, et al. ANUBI: A Platform for Affinity Optimization of Proteins and Peptides in Drug Design. Journal of Chemical Theory and Computation. 2026. doi:10.1021/acs.jctc.5c01640
BibTeX
@article{Buratto2026,
author = {Buratto, Damiano and Wang, Wanding and Zhang, Xinyi and Zhu, Qiujie and Meng, Jia and Rigden, Daniel J and Zhou, Ruhong and Zonta, Francesco},
title = {ANUBI: A Platform for Affinity Optimization of Proteins and Peptides in Drug Design},
journal = {Journal of Chemical Theory and Computation},
year = {2026},
doi = {10.1021/acs.jctc.5c01640}
}
EUVIMED